McGeeD.C., GouldM.K.Preventing complications of central venous catheterization.N Engl J Med2003; 348: 1123.
2.
O'GradyN.P., GerberdingJ.L., WeinsteinR.A., MasurH.Patient safety and the science of prevention: The time for implementing the Guidelines for the Prevention of Intravascular Catheter-Related Infections is now.Crit Care Med2003; 31: 291.
3.
MermelL.A.Prevention of intravascular catheter-related infections.Ann Intern Med2000; 132: 391.
4.
RaadI.I.. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions durino insertion.Infect Control Hosp Epidemiol1994; 15: 231.
5.
EggimannP., HacbarthS., ConstantinM.N.. Impact of a prevention strategy targeted at vascularaccess care on incidence of infections acquired in intensive care.Lancet2000; 355: 1864.
6.
GlowackiL.S.. Surveillance and prophylactic intervention of Staphylococcus aureus nasal colonization in haemodialysis unit.Am J Nephrol1994; 14: 9.
7.
KluytmansJ.A.. Elimination of nasal carriage of Staphylococcus aureus in haemodialysis patients.Infect Control Hosp Epidemiol1996; 17: 793.
8.
MakiD.G., RingerM, AlvaradoC.J.Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.Lancet1991; 338: 339.
9.
RichetH., HubertB., NitembergG.. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients.J Clin Microbiol1990; 28: 2520.
10.
HoffmannK.K., WeberD.J., SamsaG.P.. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks.JAMA1992; 267: 2072.
11.
NKFK/DOQI Guidelines for vascular access.Am J kidney Dis2001.
12.
MerrerJ., JongheB.D., GolliotF.. Complications of femoral and subclavian venous catheterization in critically ill patients. A randomized controlled trial.JAMA2001; 286: 700.
13.
WeijmerM.C.. Clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.J Am Soc Nephrol2005; 16: 2769.
14.
RaadI., DarouicheR., DuPuisJ.. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections.Ann Intern Med1997; 127: 267.
15.
VeenstraD.L., SaintS., SullivanS.D.Cost-effectiveness of antisepticimpregnated central venous catheters for the prevention of catheter-related bloodstream infection.JAMA1999; 282: 554.
16.
DunserM.W., MayrA.J., HinterbergerG.. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic impregnated catheters.Aesth Analg2005; 101: 1778.
17.
CobbD.K., HighK.P., SawyerR.G.. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters.N Engl J Med1992; 327: 1062.
18.
BarzaghiA., Dell'OrtoM., RovelliA.. Central venous catheter clots: incidence, clinical significance and catheter care in patients with hematologic malignancies.Pediatr Hematol Oncol1995; 12: 243.
19.
AbdelkefiA., TorjmanL., LadebS.. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.J Clin Oncol2005; 23: 7864.
20.
AppelgrenP., RansjoU., BindslevL.. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: Results from a prospective randomized trial.Crit Care Med1996; 24: 1482.
